Your browser doesn't support javascript.
loading
Strengthening causal inference from randomised controlled trials of complex interventions.
Leroy, Jef L; Frongillo, Edward A; Kase, Bezawit E; Alonso, Silvia; Chen, Mario; Dohoo, Ian; Huybregts, Lieven; Kadiyala, Suneetha; Saville, Naomi M.
Afiliação
  • Leroy JL; Poverty, Health, and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA j.leroy@cgiar.org.
  • Frongillo EA; Department of Health Promotion, Education, and Behavior, University of South Carolina, Columbia, South Carolina, USA.
  • Kase BE; Department of Health Promotion, Education, and Behavior, University of South Carolina, Columbia, South Carolina, USA.
  • Alonso S; Animal and Human Health Porgram, International Livestock Research Institute, Nairobi, Kenya.
  • Chen M; Biostatistics and Data Sciences, FHI 360, Durham, North Carolina, USA.
  • Dohoo I; Health Management, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.
  • Huybregts L; Poverty, Health, and Nutrition Division, International Food Policy Research Institute, Washington, District of Columbia, USA.
  • Kadiyala S; The London School of Hygiene & Tropical Medicine, London, UK.
  • Saville NM; Institute for Global Health, University College London, London, UK.
BMJ Glob Health ; 7(6)2022 06.
Article em En | MEDLINE | ID: mdl-35688484
Researchers conducting randomised controlled trials (RCTs) of complex interventions face design and analytical challenges that are not fully addressed in existing guidelines. Further guidance is needed to help ensure that these trials of complex interventions are conducted to the highest scientific standards while maximising the evidence that can be extracted from each trial. The key challenge is how to manage the multiplicity of outcomes required for the trial while minimising false positive and false negative findings. To address this challenge, we formulate three principles to conduct RCTs: (1) outcomes chosen should be driven by the intent and programme theory of the intervention and should thus be linked to testable hypotheses; (2) outcomes should be adequately powered and (3) researchers must be explicit and fully transparent about all outcomes and hypotheses before the trial is started and when the results are reported. Multiplicity in trials of complex interventions should be managed through careful planning and interpretation rather than through post hoc analytical adjustment. For trials of complex interventions, the distinction between primary and secondary outcomes as defined in current guidelines does not adequately protect against false positive and negative findings. Primary outcomes should be defined as outcomes that are relevant based on the intervention intent and programme theory, declared (ie, registered), and adequately powered. The possibility of confirmatory causal inference is limited to these outcomes. All other outcomes (either undeclared and/or inadequately powered) are secondary and inference relative to these outcomes will be exploratory.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos Controlados Aleatórios como Assunto Idioma: En Ano de publicação: 2022 Tipo de documento: Article